Adipose tissue-derived microvascular fragments represent promising vascularisation units for implanted tissue constructs. However, their reassembly into functional microvascular networks takes several days, during which the cells inside the implants are exposed to hypoxia. In the present study, we analysed whether this critical phase may be overcome by pre-cultivation of fragment-seeded scaffolds prior to their implantation. Green fluorescent protein (GFP)-positive microvascular fragments were isolated from epididymal fat pads of male C57BL/6-TgN (ACTB-EGFP) 1Osb/J mice. Nano-size hydroxyapatite particles/poly (ester-urethane) scaffolds were seeded with these fragments and cultivated for 28 days. Subsequently, these scaffolds or control scaffolds, which were freshly seeded with GFP-positive microvascular fragments, were implanted into the dorsal skinfold chamber of C57BL/6 wild-type mice to study their vascularisation and incorporation by means of intravital fluorescence microscopy, histology and immunohistochemistry over 2 weeks. Pre-cultivation of microvascular fragments resulted in the loss of their native vessel morphology. Accordingly, pre-cultivated scaffolds contained a network of individual CD31/GFP-positive endothelial cells with filigrane cell protuberances. After implantation into the dorsal skinfold chamber, these scaffolds exhibited an impaired vascularisation, as indicated by a significantly reduced functional microvessel density and lower fraction of GFPpositive microvessels in their centre when compared to freshly seeded control implants. This was associated with a deteriorated incorporation into the surrounding host tissue. These findings indicate that freshly isolated, noncultivated microvascular fragments should be preferred as vascularisation units. This would also facilitate their use in clinical practice during intra-operative one-step procedures.
Introduction
The success of tissue engineering approaches depends on the establishment of an adequate vascularisation, which provides the basis for the onset of regenerative processes and guarantees the survival of cell-seeded implants (Laschke et al., 2006; Auger et al., 2013) . Accordingly, various vascularisation strategies have been tested during the last years, ranging from the stimulation of angiogenesis at the defect site by sophisticated growth factor delivery systems to the generation of preformed microvascular networks inside tissue constructs prior to their implantation (Phelps and García, 2010; Novosel et al., 2011) . By now, particularly the latter approach is considered to be a promising option, because the rapid interconnection of preformed microvessels with the surrounding microvasculature may markedly shorten the critical time period, during which an implant is exposed to hypoxia Laschke and Menger, 2012) .
Adipose tissue-derived stromal cells represent an attractive source for the generation of prevascularised tissue constructs due to their high vessel-forming capacity . This heterogeneous population of isolated multipotent stem cells, endothelial cells, pericytes and haematopoietic cells has been shown to assemble into microvascular networks when seeded onto different scaffold types Güven et al., 2011; Laschke et al., 2013; Klar et al., 2014) . Moreover, the cells promote angiogenesis and vessel maturation by secreting various pro-angiogenic and regulatory proteins (Matsuda et al., 2013; Rohringer et al., 2014) .
Alternatively to adipose tissue-derived single cell suspensions, intact microvascular fragments may be used as effective prevascularisation units for tissue constructs (Laschke et al., 2012; Laschke et al., 2014a) . These mixed arteriolar, capillary and venular vessel segments can also be easily isolated in large amounts from fat tissue samples by enzymatic digestion within a short period of time (Hoying et al., 1996; Shepherd et al., 2004; Nunes et al., 2010a) . Importantly, they do not only exhibit a fully functional vessel morphology directly after isolation, but also contain mesenchymal stem cells and endothelial progenitor cells, which may further improve their regenerative potential (Laschke et al., 2012; McDaniel et al., 2014) . Accordingly, microvascular fragments have already been successfully used to improve the perfusion of different tissue constructs, including muscle, cardiac and islet implants (Shepherd et al., 2007; Hiscox et al., 2008; Pilia et al., 2014) .
After their incorporation into porous scaffolds, microvascular fragments exhibit a high angiogenic MW Laschke et al. Pre-cultivation of microvascular fragments activity and reassemble in vivo to functional microvascular networks, which are finally blood-perfused by the process of external inosculation (Laschke et al., 2012) . However, although this approach circumvents de novo vessel formation inside the scaffolds, it still does not result in their sufficient blood perfusion during the first 3-6 days after implantation. This is because the formation of a new microvasculature, based on microvascular fragments, also requires a time-consuming sequence of distinct vascular phenotypes, including sprouting angiogenesis, neovascular formation and network maturation (Nunes et al., 2010b) .
To overcome this problem, we analysed in the present study whether it is possible to generate complete microvascular networks by pre-cultivation of microvascular fragments inside porous scaffolds under pro-angiogenic culture conditions. We hypothesised that these networks are already in a mature stage at the time point of implantation and, thus, simply have to develop interconnections to the surrounding vessels to get fully perfused within a short period of time. To test this hypothesis, we implanted pre-cultivated scaffolds and control scaffolds, which were freshly seeded with microvascular fragments, into mouse dorsal skinfold chambers to analyse their vascularisation and incorporation by means of repetitive intravital fluorescence microscopy, histology and immunohistochemistry.
Materials and Methods

Animals
For the experiments we used male transgenic C57BL/6-TgN (ACTB-EGFP)1Osb/J mice (The Jackson Laboratory, Maine, USA) with an average age of 8 months and a body weight of 30-36 g as fat donors and corresponding male C57BL/6 wild-type mice (Charles River, Sulzfeld, Germany) with an average age of 3-4 months and a body weight of 22-26 g for the preparation of dorsal skinfold chambers. The animals were housed one per cage and had free access to tap water and standard pellet food (Altromin, Lage, Germany). All experiments were approved by the local governmental animal care committee and were conducted in accordance with the German legislation on protection of animals and the NIH Guidelines for the Care and Use of Laboratory Animals (NIH Publication #85-23 Rev. 1985) .
Isolation of microvascular fragments, seeding of scaffolds and pre-cultivation Microvascular fragments were isolated from epididymal fat pads of male C57BL/6-TgN (ACTB-EGFP)1Osb/J donor mice (Okabe et al., 1997) , as described previously in detail (Laschke et al., 2012) . This approach allowed an easy detection of the microvascular fragments by their GFP-positive signal throughout the experiments.
Directly after the isolation procedure, the microvascular fragments were seeded on porous nano-size hydroxyapatite particles/poly(ester-urethane) composite scaffolds with a size of ~ 3 × 3 × 1 mm, which were fabricated by a salt leaching-phase inverse process and exhibited interconnected macropores of ~ 220 µm (Laschke et al., 2010a) . For this purpose, the scaffolds were fixed in the lumen of a modified 1 mL syringe (BD Plastipak; BD Biosciences, Heidelberg, Germany). The tip of the syringe was filled with 20 µL PBS containing the microvascular fragments. Negative and positive pressure was alternately induced three to five times in the syringe so that the microvascular fragments could pass the scaffolds from both sides and were finally trapped in the scaffold pores (Laschke et al., 2012) . Finally, the scaffolds were carefully taken out of the syringe and transferred into endothelial cell growth medium MV (PromoCell, Heidelberg, Germany) supplemented with 25 ng/mL vascular endothelial growth factor (VEGF; Promokine, Heidelberg, Germany) and 25 ng/mL fibroblast growth factor (FGF)-β (Promokine). They were cultivated at 37 °C in a humidified atmosphere with 5 % CO 2 for 3, 7, 14 or 28 days with medium change every 2 days. Subsequently, the scaffolds were embedded for histological analyses (samples from day 3, 7, 14 or 28) or implanted into dorsal skinfold chambers for further in vivo experiments (samples from day 28). As controls, we used freshly seeded scaffolds, which were not precultivated prior to their implantation.
Dorsal skinfold chamber model
Freshly seeded scaffolds and scaffolds, which were precultivated for 28 days, were implanted into the dorsal skinfold chamber of C57BL/6 wild-type mice to analyse their vascularisation by means of repetitive intravital fluorescence microscopy (Fig. 1a) . For the preparation of the chamber, the animals were anaesthetised by intraperitoneal (i.p.) injection of ketamine (75 mg/kg body weight; Ursotamin, Serumwerk Bernburg AG, Bernburg, Germany) and xylazine (25 mg/kg body weight; Rompun, Bayer, Leverkusen, Germany). A detailed description of the stepwise preparation of the dorsal skinfold chamber has been given previously by Laschke et al. (2011a) . After the surgical procedure the animals were allowed to recover for 48 h in order to exclude deterioration of the microcirculation due to anaesthesia and surgical trauma. Subsequently, the cover glass of the dorsal skinfold chamber was temporarily removed and one scaffold was placed onto the striated muscle tissue within the centre of each chamber, taking care to avoid contamination, mechanical irritation or damage of the tissue (Fig. 1b) .
Intravital fluorescence microscopy and microcirculatory analysis
For intravital fluorescence microscopy, 0.05 mL 5 % fluorescein isothiocyanate (FITC)-labelled dextran 150,000 (Sigma-Aldrich, Taufkirchen, Germany) was injected intravenously (i.v.) via the retrobulbary space of the anaesthetised mice. This provided adequate contrast enhancement by staining of blood plasma. The animals were then fixed on a Plexiglas stage and the observation window of the chamber was horizontally positioned under the microscope. The microscopy was performed using a Zeiss Axiotech microscope (Zeiss, Oberkochen, Germany) with a 100 W mercury lamp, which was attached to an epi-illumination filter block for blue, green and ultraviolet light (Laschke et al., 2013) . The microscopic images were recorded by a charge-coupled device video camera
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The microscopic images were analysed by means of the software package CapImage (Zeintl, Heidelberg, Germany). Vascularisation of the scaffolds was evaluated at a magnification of ×460 in 8 different microvascular regions of interest (ROIs) within the border zone and 8 different microvascular ROIs within the centre of the implants (Fig. 1c) . Perfused ROIs (given in % of all analysed ROIs) were defined as areas, which exhibited either newly developed red blood cell (RBC)-perfused microvessels or reperfused microvascular fragments. In addition, the functional microvessel densities, i.e. the lengths of all RBC-perfused blood vessels per ROI, were measured and are given in cm/cm² (Laschke et al., 2012) .
Experimental protocol
Microvascular fragments were isolated from epididymal fat pads of 12 male C57BL/6-TgN(ACTB-EGFP)1Osb/J mice and seeded on 20 porous scaffolds. Directly after the seeding procedure (n = 4) or after 28 days of pre-cultivation (n = 4), serial sections of scaffolds were prepared for histological and immunohistochemical analyses to assess vessel distribution and morphology on 5 different sections per sample. The other scaffolds, which were pre-cultivated for 3 (n = 3), 7 (n = 3), 14 (n = 3) and 28 days (n = 3) were additionally stained with trypan blue for the assessment of cell viability. For this purpose, the scaffolds were incubated in 0.2 % trypan blue (Sigma-Aldrich) for 10 min at 37 °C. After washing in PBS for 10 min, the samples were fixed in 4 % formalin for further histological processing.
To analyse the vascularisation of the scaffolds in vivo, microvascular fragments from 12 male C57BL/6-TgN(ACTB-EGFP)1Osb/J mice were seeded on 16 scaffolds, which were either pre-cultivated for 28 days (n = 8) or directly implanted (n = 8) into the dorsal skinfold chamber of 16 C57BL/6 wild-type mice. Intravital fluorescence microscopy of the implants' vascularisation was performed directly after implantation as well as at days 3, 6, 10 and 14. At the end of the in vivo experiments, the animals were sacrificed with an overdose of the anaesthetic and the dorsal skinfold preparations were excised for further histological and immunohistochemical analyses.
Histology and immunohistochemistry
For light microscopy, formalin-fixed specimens of freshly seeded or pre-cultivated scaffolds as well as dorsal skinfold preparations with the scaffold implants were embedded in paraffin. 3 µm sections were cut and stained with haematoxylin and eosin (HE) according to standard procedures. Sections of trypan blue-incubated scaffolds were counterstained with 0.1 % nuclear fast red (Sigma-Aldrich) and examined under a BX60 microscope (Olympus, Hamburg, Germany) for the quantitative analysis of dead cells (marked in blue, given in %) within the samples.
For immunohistochemical detection of endothelial cells and stabilising perivascular cells of microvascular fragments, sections were stained with a monoclonal rat-anti-mouse antibody against CD31 (1:30; dianova GmbH, Hamburg, Germany) and with a rabbit-anti-mouse antibody against α-smooth muscle actin (SMA) (1:100; Abcam, Cambridge, UK). A goat-anti-rat Cy3 antibody (FK6990; Pieper, Schwerte, Germany) and transferred to a DVD system for off-line analysis. By means of 5×, 10× and 20× long-distance objectives (Zeiss) magnifications of ×115, ×230 and ×460 were achieved on a 14 inch video screen (Trinitron; Sony, Tokyo, Japan).
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(1:50; dianova GmbH) and a goat-anti-rabbit Alexa488 antibody (1:100; Invitrogen, Darmstadt, Germany) served as secondary antibodies. On each section, cell nuclei were stained with Hoechst 33342 (1:500; Sigma-Aldrich) to merge the images exactly. For immunohistochemical detection of GFP-positive and -negative microvessels, sections were stained with a monoclonal rat-anti-mouse antibody against CD31 (1:30; dianova GmbH) to detect endothelial cells and with a goat-anti-GFP antibody (1:200; Biomol, Hamburg, Germany) to enhance GFP-fluorescence. As secondary antibodies a goat-anti-rat Cy3 antibody (1:50; dianova GmbH) and a biotin-labeled donkey-anti-goat antibody (1:15; Jackson ImmunoResearch, Baltimore, MD, USA), which was detected by fluorescein labelled-streptavidin (1:50; Vector Labs, Burlingame, CA, USA), were used. For this purpose, the sections were placed in Coplin jars with 0.05 % citraconic anhydride solution (pH 7.4) for 1 h at 98 °C and then incubated overnight at 4 °C with the primary antibody, followed by the appropriate secondary antibody at 37 °C for 2 h. On each section, cell nuclei were stained with Hoechst 33342 (1:500; Sigma-Aldrich) to merge the images exactly. For the quantitative analysis of the density (given in mm -2
) and the fraction of GFP-positive and -negative microvessels (given in %) in the border and centre of the implants, the sections were examined using the BX60 microscope (Olympus).
Statistics
After testing the data for normal distribution and equal variance, differences between two groups were analysed by the unpaired Student's t-test. To test for time effects in the individual groups, ANOVA for repeated measures was applied. This was followed by the Student-Newman-Keuls 
Results
Histomorphology of freshly seeded and precultivated scaffolds in vitro
In a first set of experiments, we characterised in vitro the morphology of freshly seeded and pre-cultivated scaffolds by means of histology and immunohistochemistry. These analyses revealed that the microvascular fragments were randomly distributed on the surface and inside central pores of freshly seeded control scaffolds. Because these fragments originated from mature microvascular networks of fat tissue samples, they comprised a heterogeneous mixture of arteriolar, venular and capillary segments, which were partly surrounded by residual connective tissue components and exhibited a typical vessel morphology with a lumen surrounded by an endothelial layer and perivascular cells (Fig. 2a) . As expected, additional immunohistochemical analyses of the microvascular fragments showed that they stained double-positive for the endothelial cell marker CD31 and for GFP (Figs. 2c-e) . In contrast, scaffolds, which were pre-cultivated for 28 days, presented with a completely different histomorphology. They contained a network of thin, elongated cells, which grew along the scaffold strands (Fig.  2b) . Of interest, immunohistochemical detection of CD31 and GFP revealed that many of these cells originated from the endothelium of the microvascular fragments (Figs. 2f-h ). However, vessel segments with a lumen surrounded by endothelial cells were not detectable anymore.
To analyse in more detail the progressive vessel dedifferentiation throughout the pre-cultivation period of 28 days, we stained microvascular fragments inside scaffolds, which were pre-cultivated for 0, 3, 7, 14 and 28 days, with antibodies against the endothelial cell marker CD31 and the perivascular cell marker α-SMA (Figs. 3a-e) . By this, we could demonstrate that the fragments continuously lost their α-SMA-positive perivascular cell coverage over time. In parallel, we detected a progressive disorganisation of the endothelial cells. Additionally, we analysed the cell viability within the scaffolds at day 3, 7, 14 and 28 (Figs. 3f-i) . At each time point, we detected a comparably low number of trypan blue-positive dead cells within the samples (3 d: 8 ± 3 %; 7 d: 5 ± 2 %; 14 d: 7 ± 3 %; 28 d: 4 ± 2 %), indicating that the cultivation conditions did not markedly affect their viability.
Vascularisation of implanted scaffolds in vivo
Based on our in vitro observation of a continuous vessel regression throughout the pre-cultivation period of 28 days we decided to implant only freshly seeded scaffolds as controls and scaffolds, which were pre-cultivated for 28 days, into the dorsal skinfold chamber to characterise the effects of these two extreme conditions on the in vivo vascularisation of the implants.
Directly after implantation into the dorsal skinfold chamber of C57BL/6 wild-type mice, individual GFPpositive microvascular fragments could be easily detected Fig. 3 . a-e: Immunohistochemical characterisation of microvascular fragments within a freshly seeded control scaffold (a) and scaffolds, which were pre-cultivated for 3 (b), 7 (c), 14 (d) and 28 days (e). Note the continuous loss of the stabilising α-SMA-positive perivascular cell coverage and the progressive disorganisation of the endothelial cells. Histological sections were stained with Hoechst 33342 to identify cell nuclei (a-e, blue), an antibody against CD31 for the detection of endothelial cells (a-e, red) and an antibody against α-SMA (a-e, green). Scale bars: 15 µm. f-i: Nuclear fast red-stained sections of trypan blue-incubated scaffolds, which were pre-cultivated for 3 (f), 7 (g), 14 (h) or 28 days (i). Note that all samples only contain a very low number of trypan blue-positive dead cells (f-i, arrows). Scale bars: f-i = 20 µm.
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Fig. 4. a, b:
Intravital fluorescence microscopy of a freshly seeded control scaffold (a) and a pre-cultivated scaffold (b) directly after implantation into the dorsal skinfold chamber of a C57BL/6 mouse. In the control scaffold, a GFPpositive microvascular fragment (a, arrow) is visualised on the surface in blue-light epi-illumination. In contrast, the surface of the pre-cultivated scaffold is covered by a network of interconnected GFP-positive cells with filigrane cell protuberances (b, arrows). Scale bars: 40 µm. c-f: Intravital fluorescence microscopy in blue-light epi-illumination with contrast enhancement by 5 % FITC-labelled dextran 150,000 i.v. of the border (c, d) and centre (e, f) of a freshly seeded control scaffold (c, e) and a pre-cultivated scaffold (d, f) at day 14 after implantation into the dorsal skinfold chamber. Note that the control scaffold exhibits a markedly improved vascularisation in the centre (e) when compared to the pre-cultivated implant (f). Scale bars: 55 µm. g-j: Perfused ROIs (%) (g, h) and functional microvessel density (i, j) within the border (g, i) and the centre (h, j) of freshly seeded control scaffolds (white circles, n = 8) and pre-cultivated scaffolds (black circles, n = 8) after implantation into dorsal skinfold chambers, as assessed by intravital fluorescence microscopy and computer-assisted image analysis. Means ± SEM. 
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on the surface of freshly seeded control scaffolds by means of intravital fluorescence microscopy ( Fig. 4a) .
In line with our histological analyses, the surface of pre-cultivated scaffolds was covered by a network of interconnected GFP-positive cells with filigrane cell protuberances (Fig. 4b) . Despite this different morphology, both scaffold types induced a comparable angiogenic host tissue response in their border zones (Figs. 4c, d, g and i) . This was characterised by the formation of vessel sprouts, which progressively grew from the surrounding host microvasculature into the implants and finally interconnected with each other to form new microvascular networks.
In contrast, the vascularisation of the implants' centre markedly differed between freshly seeded and precultivated scaffolds. As already described in our previous study (Laschke et al., 2012) , freshly isolated microvascular fragments are able to proliferate and interconnect with each other and with ingrowing host vessels over time. This process could not be observed in pre-cultivated implants. Accordingly, freshly seeded control scaffolds exhibited an improved vascularisation in their centre, as indicated by a significantly higher number of perfused ROIs and increased functional microvessel density between days 10 and 14 when compared to pre-cultivated scaffolds (Figs.  4e, f, h and j) . HE-stained sections of a freshly seeded control scaffold (a, borders marked by broken line) and a precultivated scaffold (b, borders marked by broken line) at day 14 after implantation onto the host striated muscle tissue (arrows) within the dorsal skinfold chamber of C57BL/6 mice. Note that most of the pores of freshly seeded control scaffolds are filled with a dense, newly formed granulation tissue (a, asterisks), whereas the pores in precultivated implants solely contain loosely distributed cells. Scale bars: 320 µm. c-f: Immunohistochemical detection of CD31-positive microvessels (red) in the border (c, d) and centre (e, f) of a freshly seeded control scaffold (c, e) and pre-cultivated scaffold (d, f) at day 14. The sections are stained with Hoechst 33342 to identify cell nuclei. Scale bars: 40 µm. g, h: Microvessel density (mm -2 ) (g) and GFP-positive microvessels (h) within the border and centre of freshly seeded control (white bars, n = 8) and pre-cultivated scaffolds (black bars, n = 8) at day 14 after implantation into dorsal skinfold chambers, as assessed by immunohistochemical analysis. Means ± SEM *p < 0.05 vs. control.
Incorporation and angioarchitecture of implanted scaffolds At the end of the in vivo experiments, i.e. day 14 after implantation into the dorsal skinfold chamber, the scaffolds were additional analysed by histology and immunohistochemistry. By this, we could demonstrate that most of the pores of freshly seeded control scaffolds were filled with a dense, newly formed granulation tissue, whereas the pores of implants, which were pre-cultivated for 28 days, solely contained a few, loosely distributed cells (Figs. 5a and b ). This indicates a better incorporation of freshly seeded control scaffolds. In addition, we found that the granulation tissue in the centre of control scaffolds presented with a higher density of CD31-positive microvessels when compared to precultivated implants (Figs. 5c-g ). Of interest, we detected GFP-positive microvessels in the border and centre zones of both scaffold types. However, the fraction of these vessels was significantly reduced to ~ 40 % in the centre of pre-cultivated implants when compared to controls (~ 90 %) (Fig. 5h) .
Discussion
Prevascularisation of tissue constructs is a promising strategy for the rapid establishment of an adequate blood supply after their implantation into a defect site. For the generation of preformed microvascular networks inside scaffolds, various in vitro and in situ approaches have been suggested so far (Rivron et al., 2008; Laschke and Menger, 2012; Baiguera and Ribatti, 2013) . However, although these approaches have produced good results in experimental studies, they are difficult to translate into clinical practice, because they are associated with complex and time-consuming cell isolation and cultivation procedures or require repetitive surgical interventions. Accordingly, there is currently a clear trend in the field of tissue engineering towards simplified solutions, which primarily use the self-regenerative capacity of the human body.
Adipose tissue-derived microvascular fragments represent promising vascularisation units. In contrast to single cell isolates from the stromal fraction of fat tissue , these fragments bear the major advantage that they already consist of fully functional arteriolar, capillary and venular vessel segments. Under clinical conditions, these fragments may be isolated from a patient by minimally-invasive liposuction and directly transferred to a defect site in an intra-operative one-step procedure. Recently, we and others reported that these fragments possess the capacity to reassemble into fully functional microvascular networks (Shepherd et al., 2004; Shepherd et al., 2007; Laschke et al., 2012) . This, however, requires several days during which the cells inside implanted tissue constructs are still exposed to hypoxia and, thus, may not survive. In the present study, we demonstrate now that this critical phase cannot be shortened by pre-cultivation of fragment-seeded scaffolds prior to their implantation.
For our experiments, we used the identical type of polyurethane scaffolds, as in former studies, focusing on the establishment of novel vascularisation strategies for tissue engineering (Laschke et al., 2010b; Laschke et al., 2011b; Laschke et al., 2013) . These scaffolds have originally been designed for bone tissue engineering and, thus, contain nanosize hydroxyapatite particles to improve their osteoconductivity (Laschke et al., 2010a) . Due to their elastic properties and their high porosity they are particularly suitable for the dynamic seeding with individual cells (Duttenhoefer et al., 2013) , cell spheroids (Laschke et al., 2013; Laschke et al., 2014b) and microvascular fragments (Laschke et al., 2012; Laschke et al., 2014a) .
We found that the pre-cultivation of microvascular fragments inside porous polyurethane scaffolds for 28 days results in the loss of their native vessel morphology without markedly affecting their viability. In fact, precultivated fragments continuously lost their stabilising α-SMA-positive perivascular cell coverage over time.
In parallel, we detected a progressive disorganisation of their endothelial cells, finally resulting in the loss of vessel lumina and the formation of a network of individual endothelial cells with filigrane cell protuberances, which grew along the scaffold strands. This observed vessel dedifferentiation is in line with previous studies, in which microvascular fragments or in situ generated microvascular networks partly lost their α-SMA-positive perivascular cell layers during short-term cultivation of 3-10 days (Shepherd et al., 2004; Laschke et al., 2011b) . The interaction of endothelial cells and these stabilising cell layers, in turn, is important for maintaining long-term microvascular integrity (Díaz-Flores et al., 1991; Lindahl et al., 1997) . In addition, the lack of blood perfusion during cultivation may have further contributed to the regression of individual microvascular fragments, because blood flow-induced mechanical forces have been shown to regulate endothelial cell proliferation and survival (Kadohama et al., 2007) .
When we initially planned our study, we chose a precultivation period of 28 days, because such a time frame may offer the possibility to differentiate mesenchymal stem cells, which are an important component of microvascular fragments (Laschke et al., 2012; McDaniel et al., 2014) , into tissue-specific cells prior to their transfer into a defect site. Our results now show that in vitro differentiation of mesenchymal stem cells does not contribute to the development of a functional microvascular network. With the benefit of hindsight, it is furthermore clear that a markedly shortened pre-cultivation period results in less vessel regression. However, our in vitro analyses showed that even such a short pre-cultivation period of 3-7 days is already associated with a significant loss of vessel morphology and perivascular cell stabilisation and, in addition, does not lead to our primary goal, i.e. the formation of fully functional microvascular networks inside the scaffolds.
In contrast to our results, others (Hoying et al., 1996; Shepherd et al., 2004; Shepherd et al., 2007) have shown that microvascular fragments can spontaneously reassemble in vitro to form microvascular networks. This MW Laschke et al. Pre-cultivation of microvascular fragments may be explained by the fact that they embedded the fragments in a collagen gel, which provided a specific environment similar to the extracellular matrix (ECM) of physiological tissues. During recent years, it has become evident that this ECM not only serves as a mechanical framework for newly developing microvessels, but also stimulates intracellular signalling pathways, which are crucially involved in the process of angiogenesis (Ingber, 2002; Yang et al., 2004) . Accordingly, we speculate that optimising the in vitro culture conditions by additional filling of the scaffold pores with an ECM equivalent may have improved the outcome in the present experimental setting. This approach may also bear the advantage that the ECM equivalent can be supplemented with angiogenic growth factors to promote angiogenesis and network formation inside the construct (Laschke et al., 2008) . On the other hand, it has to be considered that each additional modification of a tissue construct makes it more difficult to introduce it into clinical practice due to significant technical, regulatory and policy hurdles (Stegemann et al., 2014) . Seen from that point of view, we feel that the implantation of scaffolds seeded with freshly isolated, non-cultivated microvascular fragments is currently the most realistic strategy for potential clinical applications.
In line with our histomorphological characterisation of pre-cultivated and freshly seeded control scaffolds, intravital fluorescence microscopy revealed that both scaffold types exhibited a different vascularisation pattern after implantation into the dorsal skinfold chamber. While a comparable number of microvessels developed in the border zones of the implants, freshly seeded scaffolds presented with a markedly improved vascularisation in their centre when compared to pre-cultivated ones. Our finding that 90 % of all microvessels inside freshly seeded scaffolds stained positive for GFP indicates that this improved vascularisation was mainly caused by the reassembly of microvascular fragments into functional microvascular networks over time. This also resulted in higher tissue content inside the implants, further emphasising the importance of a sufficient vascularisation for the survival and successful incorporation of tissue constructs (Laschke et al., 2006; Auger et al., 2013) .
Despite a deteriorated vascularisation we still detected GFP-positive microvessels in the border and centre zones of pre-cultivated scaffolds at day 14 after implantation. This is an interesting result, which indicates that the endothelial cells of the original microvascular fragments still contributed to the development of a new microvasculature inside the implants, even after the long pre-cultivation period of 28 days. The comparable vascularisation in the border zones of pre-cultivated and control scaffolds may be best interpreted as an unspecific angiogenic host tissue response due to the vitalisation with cells. In fact, both implant types were vitalised with a mixture of different cells, which suffered from hypoxia during the initial phase after implantation and, thus, may have stimulated the host tissue by the release of angiogenic growth factors, such as VEGF. In line with this view, Schumann et al. (2009) demonstrated that the vascularisation of scaffolds seeded with osteoblast-like cells, bone marrow mesenchymal stem cells or a combination of both cell types is VEGF-related rather than dependent on the specific vessel-forming capacity of individual cells inside the implants.
Conclusions
The present animal study indicates that pre-cultivation of adipose tissue-derived microvascular fragments from mice inside scaffolds does not improve their in vivo vascularisation capacity, but markedly affects their physiological vessel morphology and function. If the same holds true for human adipose tissue-derived microvascular fragments, this means that freshly isolated fragments should be preferred as vascularisation units. This notion is supported by the fact that intra-operative one-step procedures with minimal in vitro manipulations are preferred for clinical tissue engineering applications.
